松齡護老集團(01989.HK)原控股股東停止向鄧成波及其家人追款申索
松齡護老集團(01989.HK)公布,就有關原控股股東Pine Active Care向鄧成波及其家人追討之3筆款項,目前第三筆代價付款的未償還餘額為1.25億元,公司獲進一步告知,有關申索的申請已中止,及於2021年3月31日前,第三筆代價付款的所有未償還餘額將悉數償還。
公司並非上述買方與Pine Active Care Limited之間安排的一方,且公司獲告知,訂約方已定下時間表並結清有關買賣協議項下擬進行交易的所有未償還款項,董事會認為該事件不會對公司的業務產生任何營運方面的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.